Navigation Links
Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
Date:10/12/2007

CAMBRIDGE, Mass., Oct. 12 /PRNewswire-FirstCall/ -- Genzyme Corporation (Nasdaq: GENZ) announced that the U.S. Food and Drug Administration's Cardiovascular and Renal Products Advisory Committee will meet Tuesday to consider the use of phosphate binders in patients with chronic kidney disease (CKD) who are not on dialysis.

FDA asked the three companies that currently market phosphate binders for patients on dialysis to provide perspective that will help the agency formulate its approach to extending the use of phosphate binders to pre- dialysis patients. In a briefing package provided to the FDA and the committee, the companies have outlined their position for the committee to consider. Specifically:

-- Phosphate imbalance precedes the need for dialysis in patients with

CKD, and should be treated at the time that patients begin to

experience hyperphosphatemia.

-- Left untreated, patients experiencing hyperphosphatemia prior to the

initiation of dialysis may experience progression of renal disease,

bone disorders and vascular calcification.

-- Hyperphosphatemia is an independent risk factor for cardiovascular

morbidity and mortality, and for the progression of renal failure in

the pre-dialysis population.

-- And the risk-benefit profile of appropriate early treatment of

hyperphosphatemia in CKD patients not on dialysis is favorable.

The committee is expected to vote on several questions related to the use of phosphate binders in pre-dialysis patients, concluding with a vote on whether the committee recommends that the FDA extend the indications for phosphate binders to use in these patients. The briefing package and th
'/>"/>

SOURCE Genzyme Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cytochroma settles lawsuit with Genzyme
2. Genzyme sues former Bone Care employees
3. Genzyme acquistion of Bone Care approved, significant impact forecast
4. Bruker Participates in Dutch Funded Super Microscope Project
5. Quintessence Biosciences forms cancer therapeutic advisory board
6. GenTel Appoints Burke to its Scientific Advisory Board
7. Wisconsin spaceport committee moves closer to formation
8. Thompson To Chair MDVIP Committee On Preventive Healthcare
9. Finance Committee rejects extra tax on Internet buys
10. UN committee opposes human cloning
11. Merges Simon Elected to DICOM Standards Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... Ariz., Aug. 27 MedPredict has published a,new ... Insight &,Analysis: Breast Cancer," designed to provide critical ... stake in the market for diagnostics,and treatments in ... European breast cancer thought leaders to identify the ...
... are urged to put auto-injectable ... the school supplies list, SILVER SPRING, Md., Aug. 27 ... Nurses (NASN) found that 72% of school,nurses have students with ... parents have not provided the school with auto-injectable,epinephrine. Also known ...
... Aug. 27 MDdatacor, Inc., a leader in ... providers, announced,today that CMS has approved the company ... Medicaid Services (CMS)., MDdatacor will automate the ... the administrative burden of having to,hand-write data collection ...
Cached Biology Technology:Pipeline for Breast Cancer Therapies is Focus of New MedPredict Report 2Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School 2Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School 3Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School 4MDdatacor Designated as Approved Vendor by CMS for Physician Quality Reporting Initiative 2
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ... accuracy is the ultimate driver in long-term mass consumer ...
(Date:12/10/2014)... Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ... "Biometrics Market in Japan 2014-2018" report to ... The integration of biometrics and ... and upgradation of the driver,s license is one ... Besides the aforementioned projects, biometrics is being used ...
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... is one of many important crop species that is ... commonly used to work with crops. Researchers, reporting in ... the first high-throughput forward and reverse genetics tool for ... crop breeders around the world.. Researchers from the ...
... years fifth annual Bonefish Population Census in the Florida ... from 2006, however, the number of volunteers participating in ... Ault, Ph.D., University of Miami Rosenstiel School of Marine ... thats exactly the type of fish stock numbers and ...
... 2008 -- A team of scientists led by Washington University ... of corn, a crop vital to U.S. agriculture. The researchers ... accomplishment that should accelerate efforts to develop better crop varieties ... fuel. , Corn, also known as maize, underlies myriads ...
Cached Biology News:Scientists unravel the genetic coding of the pea 25th annual Keys bonefish population census results announced 2Washington University unveils draft sequence of corn genome 2Washington University unveils draft sequence of corn genome 3
... between P-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) ... the lumenal surface of endothelial cells at ... primary role of PSGL-1 in mediating the ... well documented.MAB4092 completely blocks recognition of PSGL-1 ...
Mouse Anti-Human MCAF-(MCP-1)...
Mouse VEGF R1/Flt-1 Phycoerythrin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
Recognizes Kir4.1. The epitope does not share homology with any other known proteins.,SPECIES REACTIVITIES: The antibody is also expected to work with mouse and human due to sequence homology. Oth...
Biology Products: